Endo International reported a GAAP loss of $71.974 million in the first three months of 2022, compared to a profit of $41.524 million in the previous year. Revenue decreased by 9.1% to $652.259 million from $717.919 million a year earlier.
Endo International reported a GAAP loss of $71.974 million in the first three months of 2022, compared to a profit of $41.524 million in the previous year. Revenue decreased by 9.1% to $652.259 million from $717.919 million a year earlier. 
English (US) 